Skip to main content
. 2018 Oct 16;9(5):987–1002. doi: 10.1002/jcsm.12354

Figure 2.

Figure 2

Satellite cell and myogenic markers are impaired throughout the development of cachexia. (A) Pax 7 mRNA content throughout the progression of cancer cachexia. MyoD mRNA content throughout the progression of cancer cachexia. CyclinD1 content throughout the progression of cancer cachexia. MyoG content throughout the progression of cancer cachexia. N of 7–8 was utilized for each group. Lettering denotes statistical significance (means that do not share the same letter are statistically different) at an alpha set at P < 0.05.